(3-pyridyl)-1-butanone (NNK*), is present in cigarette smoke 1 To whom correspondence should be addressed and is a potent lung carcinogen in mice, rats and hamsters The tobacco-specific nitrosamine 4-(methylnitrosamino)-1-independent of the route, and type of administration (4,5).
and is a potent lung carcinogen in mice, rats and hamsters The tobacco-specific nitrosamine 4-(methylnitrosamino)-1-independent of the route, and type of administration (4, 5) .
(3-pyridyl)-1-butanone (NNK) is a potent lung carcinogen
Considering its levels in tobacco smoke and its carcinogenic in mice and is most likely involved in the aetiology of potency, Wynder and Hoffmann suggested that NNK plays a tobacco-induced lung cancer. Two protocols using NNK causative role in the development of smoking-related lung and A/J mice have been developed. In the single-dose adenocarcinomas (6, 7) . The use of NNK in the induction of protocol, each mouse was injected once with 2 mg of NNK.
lung tumours in laboratory animals is particularly relevant to In the 7-week protocol, each mouse received 9.1 mg of human lung cancer. The metabolism, DNA and protein NNK in drinking water during 7 weeks. Mice were killed alkylation by NNK are well documented (5, 8) . However its 16 weeks after NNK treatment. We observed a neareffects on the immune system have not been investigated.
Gaussian distribution in the number of tumours per mouse
Two experimental protocols have been developed in A/J in the single protocol, but not in the 7-week protocol. In mice to assess the efficacies of natural and synthetic chemothe 7-week protocol, a significant number (8.6%) of mice preventive agents. A single intraperitoneal injection of NNK had more than 20 tumours/mouse. In the single-dose at a dose of 2 mg per A/J mouse is sufficient to induce an protocol, no mouse had more than 20 tumours. Sulindac average of 10-12 lung adenomas per mouse (9) . A significant at a dose of 123 mg/kg of diet inhibits lung tumourigenesis number of these adenomas progress with time to adenoin the 7-week protocol, but not in the single-dose protocol.
carcinomas (10). Hecht et al. suggested that this protocol for We observed that the inhibition of tumourigenesis in the lung tumour induction with NNK could be useful for determin-7-week protocol was proportional to the logarithm of the ing the efficacies of chemopreventive agents and their involvedose of sulindac between 15 and 123 mg/kg of diet. Treatment in preventing the initiation or promotion stages of ment of mice for 7 weeks inhibits the primary humoral carcinogenesis (9) . Various investigators have used this single response to sheep red blood cells by 70%. This observation dose protocol to demonstrate the efficacies of 4-ipomeanol, is particularly significant considering that NNK is present diallyl sulphide, indole-3-carbinol, citrus fruit oils, arylalkyl in tobacco smoke and that tobacco smoking suppresses isothiocyanates and tea extracts against lung tumourigenesis both the specific and non-specific humoral and cellular (11) (12) (13) (14) (15) (16) . A second model using the same carcinogen and strain immunity. Single injections of 2.0, 3.5 or 5.0 mg of NNK of mice was developed in our laboratory. According to this had no effect on this response. Our results suggest that the protocol, mice are given NNK in the drinking water during 7 immunosuppressive effects of NNK contribute to its high weeks (17) . The numbers of lung adenomas per mouse average carcinogenic potency particularly in sustained or life-time 8.4 (18) . Using this protocol, we demonstrated the efficacies exposure models. We hypothesize that sulindac promotes of ellagic acid, butylated hydroxyanisole and various nonthe recovery of immune system from the NNK-mediated steroidal anti-inflammatory drugs (NSAIDs) in the inhibition suppression observed in the 7-week protocol. This study of lung tumour development (18) (19) (20) . illustrates the importance of selecting the most appro-
The aims of this study were to compare the statistical priate protocol of carcinogen treatment in investigating the distribution of lung adenoma multiplicities and to compare the efficacies of cancer chemopreventive agents.
chemopreventive efficacies of sulindac in the above-described protocols. The advantages and limitations of the two protocols in chemoprevention studies are discussed and the effects of the two protocols on the primary humoral response are Introduction compared. Cancer chemoprevention is a multistage strategy aim to reduce or delay the process of carcinogenesis. According to this Materials and methods strategy, potential agents are initially identified and tested for Figure 4 ). The diets were given starting two weeks before NNK treatment and throughout the experiment (25 weeks). One control group of 10 mice was not treated with NNK and was given AIN-76A diet (group no. 4, Table I ). Two groups of 25 mice were given NNK in drinking water and received AIN-76A diet with (group no. 6) or without (group no. 5) sulindac at a concentration of 123 mg/kg of diet. Mice were killed 23 weeks after starting NNK treatment in drinking water.
Lungs and major organs were fixed in Tellyesniczky's fixative for 7 days before counting the number of surface adenomas under a dissecting microscope as described previously (21). The stomachs were fixed in situ with 0.5 ml of 10% formalin, excised and stored in formalin. Papillomas larger than 1 mm were counted.
Stability of sulindac in the diet
Diet samples containing 123 mg of sulindac/kg were collected before feeding or at the end of a 4-day period of feeding. Two g samples of diet were extracted with 20 ml of acetonitrile: 0.01 N HCl (9:1). A 100 µl aliquot of indomethacin (100 µg/ml acetonitrile) was added as internal standard to 2 ml of supernatants. Samples were evaporated to dryness and resuspended in 200 µl of HPLC mobile phase. The extraction was repeated once. Sulindac stability was determined by reverse phase HPLC on a C-18 µBondapak column (Waters Associates, Milford, MA). The mobile phase consists of acetonitrile : KH 2 PO 4 50 mM, pH 3.7 (55:45, v/v). Elution at a flow rate of 1 ml/min was monitored at 313 nm. Results were calculated from linear regression curve relating peak area to sulindac concentrations. Four days later, spleens were removed and teased through a 70-µm nylon mesh into Hank's balanced salt solution. A 100-µl aliquot of a 1:40 dilution of the splenocyte suspensions and 100 µl of SRBCs (3 ϫ10 9 /ml) were added to 1 ml solution of 0.7% agarose. Cells were plated and incubated at 37°C for 90 min. One ml of a 1:10 dilution of guinea-pig complement was added and the incubation continued for another 90 min. The number of cells secreting anti-SRBC IgM antibodies was determined in triplicate (22).
Direct haemolytic plaque-forming technique

Statistical analysis
Normality was determined with the Shapiro-Wilk test. The distribution in the single dose protocol had a p value of 0.0004, skewness value of 0.6 and kurtosis factor of 0.4. In the 7-week exposure model the distribution had a P value of 0.0001, a skewness value of 2.6 and kurtosis factor of 8.9. In the 7-week exposure model, the skewness value was 0.1 and the kurtosis factor was 0.6 after logarithm transformation.
Results
The distribution of lung tumour multiplicities in mice receiving a single-dose of NNK is shown in Figure 3 . A total of 137 mice from three experiments were included in this analysis.
Diets
The distribution follows a near-normal Gaussian distribution.
Mice were fed with a powdered AIN-76A semi-purified diet purchased from
The maximum frequency was observed at 8-12 tumours/ preparations were carried out on a weekly basis and stored in the dark at 4°C.
The distribution of lung tumour multiplicity in mice exposed
The powdered diet was given two times a week in powder feeders (Laboratory to NNK during 7 weeks is shown in Figure 3 . A total number Fig. 3 . Distribution of the number of mice according to the number of (PϽ0.01; n ϭ 5). tumours/mouse in the single-dose and 7-week exposure protocols.
The extend of inhibition of gastric tumourigenesis is also the three groups. The average number of tumours induced by related to the dose of sulindac. The incidences of forestomach a 7-week exposure to NNK was 10.88 tumours/mouse (group tumours were 20, 16, 8, 4 and 4% at doses of 0, 15, 30, 61 and 123 mg/kg diet of sulindac, respectively (data not shown). 5). Feeding mice with 123 mg/kg sulindac reduced the number Primary humoral response to SRBCs was determined in A/ of lung tumours to 5.96 tumours/mouse (45% inhibition).
J mice treated with NNK (Table II) . Single injections of 2.0, Tumour multiplicity and incidence in untreated mice was low 3.5 or 5.0 mg of NNK did not reduce the plaque-forming cells (group no. 4). Sulindac was chemically stable under the (PFC) response. A dose of 10 mg causes death and significant conditions of feeding. More than 95% of sulindac could be weight lost. In contrast, a 70%-inhibition of the PFC response recovered from the diet collected in feeders.
was observed after a seven-week treatment with a cumulative The number of lung tumours in mice exposed to NNK dose of 9.1 mg NNK. according to the 7-week exposure protocol and fed sulindac at concentrations of 15, 30, 61 or 123 mg/kg of diet is shown Discussion in Figure 4 . The multiplicity of lung tumours was inversely proportional to the logarithm of the concentration of sulindac The A/J mouse has been used extensively to determine the carcinogenic potency of synthetic and natural compounds in the diet.
(reviewed in ref. 23). This strain is particularly susceptible to confirmed by two subsequent studies showing a 51 and 52% develop adenomas that progress with time to carcinomas within inhibition at the same dose of sulindac (18,33). In this study, adenomas and then to carcinomas (24) . The morphological we observed a 45% inhibition of lung tumourigenesis with the characteristics of mouse lung carcinomas are reminiscent of same concentration of sulindac. The inhibition of tumouriadenocarcinomas observed with increased frequency in genesis was related to the logarithm of the dose of sulindac smokers (25) . Various protocols have been developed to ( Figure 4 ). This observation further supports the hypothesis that treat A/J mice with carcinogens (3,9,17,21,23,26 ) . The most sulindac could be effective in preventing lung carcinogenesis common route of administration is the i.p. route. The carcinoinduced by NNK in tobacco smokers. The daily dose of genic response of some carcinogens is higher with the i.p sulindac recommended is 400 mg corresponding to 5.7 mg/kg route than by gastric intubation (27). Our results show that body weight and to one-half of the dose (12 mg/kg body NNK is more carcinogenic by the i.p. route than by oral weight; 123 mg/kg diet) used in this study. No epidemiological administration. This is in agreement with the study of Hecht studies have investigated specifically the protective effect of et al. reporting a higher lung tumour multiplicity following sulindac intake and lung cancer risk in smokers. However, i.p. administration of NNK (3). The single-dose protocol Dchreimachers and Everson observed a reduced incidence of documented in this paper was developed by Hecht et al. lung cancer associated with increased aspirin use (34). Aspirin (9) . This protocol has the advantages of being safer since and sulindac are both anti-inflammatory agents. The protective carcinogens are handled only once. In this study, we have effect of sulindac against colon carcinogenesis in human and demonstrated that tumour multiplicity when using this singleanimals is well documented (35,36). dose protocol has a near-normal Gaussian distribution which
In this study, we reported for the first time that NNK is simplifies statistical analysis of the data (Figure 3) . Hecht immunosuppressive. This observation is particularly significant et al. suggested that the single-dose protocol could be applied considering that NNK is present in tobacco smoke and that to study selectively the initiation and promotion phases of tobacco smoking is suppressing the specific and non-specific chemicals. However, no promoter have ever been investigated.
humoral and cellular immunity (31,37,38). The immunoWe observed that feeding A/J mice with butylated hydroxysuppression observed with NNK is to some extent similar to toluene after a single NNK injection increased the lung tumour that observed with other nitrosamines. Wayneforth and Magee response two-fold (unpublished data). The single-dose model reported that a single dose of N-nitrosodimethylamine does has proven to be useful to assess the chemopreventive efficacies not reduce the number of spleen PFC in mice or in rats (39) . of agents able to block P450-mediated activation of NNK.
A single dose of N-nitrosodimethylamine has no effect on For instance, isothiocyanates administered shortly before i.p the B lymphocyte response, but suppresses the T-B cell injection of NNK inhibit P450 activity, NNK bioactivation, collaboration (40). Desjardins et al. concluded that N-nitrosodi-NNK-DNA adduct formation and prevent tumour development methylamine suppresses the IgM antibody response to SRBC in in A/J mice (28, 29) . In this study, we did not observed any mice in a time-and dose-related manner (41). The immunotoxic inhibition of lung tumourigenesis in mice fed sulindac prior potency of dialkylnitrosamines is inversely related to aliphatic to NNK injection. This observation indicates that sulindac and chain length (42). NNK is a non-symmetrical nitrosamine with its metabolites are not effective inhibitors of the activation of a methyl group as in N-nitrosodimethylamine and a four-NNK given in bolus doses. This contrasts with our previous carbon alkyl chain such as in the dialkylnitrosamines. Our observation that the sulphide metabolite of sulindac inhibited results suggest that the immunosuppressive effects of NNK the bioactivation of NNK in mouse lung explants cultured are contributing to its high carcinogenic potency particularly in vitro. (30).
in sustained or life-time exposure models developed by The rational for developing a second protocol with NNK various investigators (43) (44) (45) (46) . We hypothesized that sulindac was to expose mice to this tobacco-specific carcinogen at is helping the immune system to recover from the NNKrelatively low dose for an extended period of time, thus mediated suppression observed in the 7-week protocol, this simulating the exposure of smokers to NNK. The levels of attenuation in the immunotoxic response being mediated by NNK in the smoke of one cigarette range from 10 to 200 ng PGE 2 . In a recent study, we observed that a 7-week treatment per cigarette and tobacco smoking could last decades (31). As with NNK increased plasma levels of PGE 2 and this increase expected, a larger cumulative dose is required in this 7-week was attenuated by sulindac in a dose-related manner (47) . The protocol to induce a tumour response comparable to that inhibition of PGE 2 synthesis by sulindac and other NSAIDs observed in the single-dose model. However, the daily dose and the immunosuppressive properties of PGE 2 are well of NNK is a relatively low and is estimated to be 186 µg. In documented (48) (49) (50) . All data obtained in our laboratory this study, we observed that the multiplicities showed a nonare consistent and support the hypothesis that lung cancer symmetrical distribution from the mean number of tumours/ chemopreventive activities of NSAIDs is related to their mouse. Although we do not know the reasons for such a capacities to inhibit PGE 2 synthesis. This hypothesis provides distribution, it could reflect a larger consumption of NNK by some rationale for the absence of inhibition of tumourigenesis mice having dominant behavioural characteristics. In our by sulindac in the single-dose protocol since acute exposure protocol, five mice were housed per cage. Administration (p.o.
to NNK is not immunosuppressive. Consistent with this or i.p.) of small repetitive subdoses of NNK could be an hypothesis, indomethacin had no effect on the growth of lung alternative to this protocol (3). As expected from the DNAtumours induced by a single dose of NNK (26). It should be alkylation data, the tumourigenic responses in the single-dose mentioned that the significance of the inhibition of PGE 2 and 7-week protocols are not linear with the dose of NNK (8, 19) synthesis as a mechanism of chemoprevention of colon cancer We were the first to demonstrate that sulindac, at a dose of by sulindac is controversial (51) (52) (53) (54) . 123 mg/kg of diet, prevents lung tumourigenesis. A 53%
In summary, this study illustrates the importance of selecting inhibition of lung tumourigenicity was observed using the 7-week protocol (32). The results of this initial study were the most appropriate animal model and protocol of carcinogen 
